Clearmind Medicine signs research deal to study MEAI with tirzepatide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. SPY
7. MMED
8. CRDO
9. GOOG
10. AAPL

Go back to Clearmind Medicine signs research deal to study MEAI with tirzepatide
(NASDAQ: CMND) Delayed: 1.81 -0.02 (1.09%)
Previous Close $1.83    52 Week High $ 
Open $1.85    52 Week Low $ 
Day High $1.87    P/E N/A 
Day Low $1.79    EPS $ 
Volume 35,917